SERA PROGNOSTICS, INC. (CIK: 0001534969) EDGAR, Information, Filings... CompaniesBIO.Com

SERA PROGNOSTICS, INC.

Mailing address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, Delaware, 84109
Phone
(801) 990-0520
State location
Utah
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

SERA PROGNOSTICS, INC. (CIK: 0001534969) is an American company incorporated in the state of Utah. Head office is located at 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, Utah, 84109. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. SERA PROGNOSTICS, INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Aerts Austin	0001979974	Jun-07-2023	officer: Chief Financial Officer
Barlow Jane F	0001736026	Apr-11-2022	director
Foley Michael R	0001892321	Dec-30-2021	officer: Chief Medical Officer
Lawrence Sandra AJ	0001306386	Nov-29-2021	director
Lindgardt Zhenya	0001891299	Nov-08-2021	director
Harrison Robert Gardner	0001421563	Nov-01-2021	officer: Chief Information Officer
Kearney Paul	0001888075	Oct-01-2021	officer: Chief Data Officer
MOYES JAY M	0001191062	Jul-14-2021	officer: Chief Financial Officer
CRITCHFIELD GREGORY C	0001191080	Jul-14-2021	director, officer: Chief Executive Officer
Kamdar Kim P.	0001535065	Jul-14-2021	director
Fisher Douglas	0001572355	Jul-14-2021	officer: Chief Business Officer
Mirza Mansoor Raza	0001588389	Jul-14-2021	director
Jackson Benjamin	0001779964	Jul-14-2021	officer: General Counsel
Blue Ox Healthcare Partners SP, LLC	0001785138	Jul-14-2021	10 percent owner
BXHCP SP II, LLC	0001804589	Jul-14-2021	10 percent owner
BXHCP SP III, LLC	0001862000	Jul-14-2021	10 percent owner
Boniface John J.	0001870674	Jul-14-2021	officer: Chief Scientific Officer
Peltier John M.	0001870764	Jul-14-2021	officer: SVP of Lab Operations
Garite Thomas	0001871486	Jul-14-2021	officer: VP, Clinical Sciences
Trimble Ryan	0001871513	Jul-14-2021	director
Altomare Nadia	0001871553	Jul-14-2021	officer: Chief Commercial Officer
Phillips Joshua	0001871555	Jul-14-2021	director
Wilson Marcus Dean	0001871726	Jul-14-2021	director
Martin Nichole L.	0001872208	Jul-14-2021	officer: VP OF Q/R & HIPPA PRIV. OFF
Blue Ox Healthcare Partners, LLC	0001873840	Jul-14-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SERA PROGNOSTICS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-005590 ( Act) Size: 0 KB	Jan-14-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-005576 ( Act) Size: 0 KB	Jan-14-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-005575 ( Act) Size: 0 KB	Jan-14-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-005574 ( Act) Size: 0 KB	Jan-14-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-005573 ( Act) Size: 0 KB	Jan-14-2025
8-K	Document	Current report filing Acc-no: 0000950170-25-004909 (34 Act) Size: KB	Jan-13-2025	001-40606 25527136
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000007 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524100
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000006 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524087
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000005 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524080
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000004 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524065
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000003 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524057
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000002 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524052
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001961863-25-000001 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25524047
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-000206 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25523289
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-000205 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25523286
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-000203 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25523277
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-000201 (33 Act) Size: 0 KB	Jan-10-2025	001-40606 25523271
8-K	Document	Current report filing Acc-no: 0000950170-25-003021 (34 Act) Size: KB	Jan-07-2025	001-40606 25515791
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0000950170-25-002829 (33 Act) Size: 0 KB	Jan-07-2025	001-40606 25514882
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-002823 ( Act) Size: 0 KB	Jan-07-2025

Recent 20 filings. View all SERA PROGNOSTICS, INC. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

SERA PROGNOSTICS, INC. overview
SERA PROGNOSTICS, INC. job
SERA PROGNOSTICS, INC. stock
SERA PROGNOSTICS, INC. ownership
SERA PROGNOSTICS, INC. CEO
SERA PROGNOSTICS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.